NCT01412983

Brief Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lenses developed by Bausch + Lomb.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2011

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

August 8, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 9, 2011

Completed
23 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
2.6 years until next milestone

Results Posted

Study results publicly available

April 29, 2014

Completed
Last Updated

April 29, 2014

Status Verified

March 1, 2014

Enrollment Period

1 month

First QC Date

August 8, 2011

Results QC Date

March 27, 2014

Last Update Submit

March 27, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Visual Acuity

    The mean difference in high contrast logMAR, over all lens visual acuities (VAs) between lens groups.

    One week

Secondary Outcomes (1)

  • Overall Comfort

    One week

Study Arms (2)

Bausch & Lomb Test Lens

EXPERIMENTAL

Bausch + Lomb investigational soft contact lens

Device: Bausch & Lomb Test lens

Ciba Vision soft contact lens

ACTIVE COMPARATOR

Ciba Vision Air Optix Aqua soft contact lens

Device: Ciba Vision soft contact lens

Interventions

Lens to be worn on a daily wear basis for one week. Participants will be provided with Bausch + Lomb renu® fresh™ multi-purpose solution for daily rinsing, cleaning, and disinfecting of their lenses.

Bausch & Lomb Test Lens

Lens to be worn on a daily wear basis for one week. Participants will be provided with Bausch + Lomb renu® fresh™ multi-purpose solution for daily rinsing, cleaning, and disinfecting of their lenses.

Ciba Vision soft contact lens

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings (greater than grade 1 and/or presence of infiltrates).
  • Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
  • Be myopic and require lens correction from -0.50 to -6.00 diopters (D) in each eye.

You may not qualify if:

  • An active ocular disease, any corneal infiltrative response or are using any ocular medications.
  • Have worn gas permeable (GP) contact lenses within last 30 days or PMMA lenses within last 3 months.
  • Any Grade 2 or greater finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  • Any scar or neovascularization within the central 4mm of the cornea.
  • Have had any corneal surgery.
  • Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  • Any systemic disease affecting ocular health.
  • Using any systemic or topical medications that will affect ocular physiology or lens performance.
  • Currently wear monovision, multifocal, or toric contact lenses.
  • Allergic to any component in the study care products.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bausch & Lomb Incorporated

Rochester, New York, 14609, United States

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Dr. Robert Steffen
Organization
Bausch & Lomb

Study Officials

  • Beverly J Barna, CCRA

    Bausch & Lomb Incorporated

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2011

First Posted

August 9, 2011

Study Start

August 1, 2011

Primary Completion

September 1, 2011

Study Completion

October 1, 2011

Last Updated

April 29, 2014

Results First Posted

April 29, 2014

Record last verified: 2014-03

Locations